We report here the introduction of SARS-COV-2 C.37, a variant of interest (VOI) recently renamed "lambda" by WHO, from Peru to Italy. We discuss mutations of concern in this lineage, and evidences for impaired sensitivity to neutralizing antibody-therapeutics and vaccines. This article is protected by copyright. All rights reserved.
Introduction of SARS-COV-2 C.37 (WHO VOI lambda) from Peru to Italy
Baj, Andreina
Primo
;Novazzi, FedericaSecondo
;Genoni, Angelo;Tamborini, Antonio;Maggi, FabrizioUltimo
2021-01-01
Abstract
We report here the introduction of SARS-COV-2 C.37, a variant of interest (VOI) recently renamed "lambda" by WHO, from Peru to Italy. We discuss mutations of concern in this lineage, and evidences for impaired sensitivity to neutralizing antibody-therapeutics and vaccines. This article is protected by copyright. All rights reserved.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.